Wealth Dimensions Group Ltd. raised its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,466 shares of the company’s stock after acquiring an additional 144 shares during the quarter. Wealth Dimensions Group […]
Wealth Dimensions Group Ltd. cut its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 17.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,856 shares of the biopharmaceutical company’s stock after selling 3,391 shares during the […]
Wealth Dimensions Group Ltd. decreased its stake in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 4.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,241 shares of the social networking company’s stock after selling 58 shares during the […]
Wealth Dimensions Group Ltd. lowered its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 155,057 shares of the company’s stock after selling 1,777 shares during the […]
Wealth Dimensions Group Ltd. reduced its holdings in The Coca-Cola Company (NYSE:KO – Free Report) by 3.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,006 shares of the company’s stock after selling 313 shares during the quarter. Wealth Dimensions Group Ltd.’s holdings in […]